These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3319740)

  • 1. Potential oncogenic hazards posed by oncogene encoded proteins.
    Lowy DR
    Dev Biol Stand; 1987; 68():63-7. PubMed ID: 3319740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
    Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of oncogenes in human neoplasia.
    Aaronson SA; Tronick SR
    Important Adv Oncol; 1985; ():3-15. PubMed ID: 3916746
    [No Abstract]   [Full Text] [Related]  

  • 10. Int-1 and int-2: oncogenic proteins, mitogens and morphogens?
    Burgess AW
    Bioessays; 1988 Jan; 8(1):40-2. PubMed ID: 3284522
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myb oncogene.
    Lipsick JS; Baluda MA
    Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes related to head and neck cancer.
    Issing WJ; Wustrow TP; Heppt WJ
    Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical mechanisms of oncogene activity: proteins encoded by oncogenes. Introduction.
    Varmus H; Bishop JM
    Cancer Surv; 1986; 5(2):153-8. PubMed ID: 3536085
    [No Abstract]   [Full Text] [Related]  

  • 15. The Wnt-1 proto-oncogene regulates MAP kinase activation by multiple growth factors in PC12 cells.
    Pan MG; Wang YH; Hirsch DD; Labudda K; Stork PJ
    Oncogene; 1995 Nov; 11(10):2005-12. PubMed ID: 7478519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gag-Myb-Ets fusion oncogene alters the apoptotic response and growth factor dependence of interleukin-3 dependent murine cells.
    Athanasiou M; Mavrothalassitis GJ; Yuan CC; Blair DG
    Oncogene; 1996 Jan; 12(2):337-44. PubMed ID: 8570210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.